Compound Information | SONAR Target prediction | Name: | SODIUM beta-NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE | Unique Identifier: | SPE01503902 | MolClass: | Checkout models in ver1.5 and ver1.0 | Molecular Formula: | C21H27N7NaO17P3 | Molecular Weight: | 738.173 g/mol | X log p: | 6.741 (online calculus) | Lipinksi Failures | 3 | TPSA | 242.54 | Hydrogen Bond Donor Count: | 0 | Hydrogen Bond Acceptors Count: | 23 | Rotatable Bond Count: | 13 | Canonical Smiles: | [Na+].[O-]P(O)(=O)OC1C(O)C(COP(O)(=O)OP([O-])(=O)OCC2OC(C(O)C2O)[n+]2c ccc(c2)C(N)=O)OC1n1cnc2c(N)ncnc12 | Therapeutics: | cofactor in aryl & steroidal hydroxylation | Generic_name: | 2--MONOPHOSPHOADENOSINE 5--DIPHOSPHORIBO | Chemical_iupac_name: | NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | Drug_type: | Experimental | Drugbank_id: | EXPT02293 | Drug_category: | Aldose Reductase inhibitor | Organisms_affected: | -1 |
Species: |
4932 |
Condition: |
GPR1 |
Replicates: |
2 |
Raw OD Value: r im |
0.7747±0.0000707107 |
Normalized OD Score: sc h |
1.0594±0.0407776 |
Z-Score: |
1.6463±1.05158 |
p-Value: |
0.19178 |
Z-Factor: |
-2.71875 |
Fitness Defect: |
1.6514 |
Bioactivity Statement: |
Nonactive |
Experimental Conditions | | Library: | Spectrum | Plate Number and Position: | 17|F2 | Drug Concentration: | 50.00 nM | OD Absorbance: | 600 nm | Robot Temperature: | 26.60 Celcius | Date: | 2006-03-02 YYYY-MM-DD | Plate CH Control (+): | 0.038825±0.00074 | Plate DMSO Control (-): | 0.7356±0.03031 | Plate Z-Factor: | 0.7934 |
| png ps pdf |
5315998 |
[(2S,3S,4S,5S)-2-(6-aminopurin-9-yl)-5-[[[[(2R,3R,4R,5R)-5-(5-carbamoylpyridin-1-yl)-3,4-dihydroxy-oxola n-2-yl]methoxy-oxido-phosphoryl]oxy-oxido-phosphoryl]oxymethyl]-4-hydroxy-oxolan-3-yl]oxyphosphonic acid |
5315999 |
[(2S,3S,4S,5S)-2-(6-aminopurin-9-yl)-5-[[[[(2R,3R,4R,5R)-5-(5-carbamoylpyridin-1-yl)-3,4-dihydroxy-oxola n-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxymethyl]-4-hydroxy-oxolan-3-yl]oxyphosphonic acid |
5326949 |
[(2S,3R,4R,5R)-2-(6-aminopurin-9-yl)-5-[[[[(2R,3R,4R,5R)-5-(5-carbamoylpyridin-1-yl)-3,4-dihydroxy-oxola n-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxymethyl]-4-hydroxy-oxolan-3-yl]oxyphosphonic acid |
5327137 |
[(2R,3R,4R)-2-(6-aminopurin-9-yl)-5-[[[[(3R,4R,5R)-5-(5-carbamoylpyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl ]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxymethyl]-4-hydroxy-oxolan-3-yl]oxyphosphonic acid |
5702267 |
sodium [(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-(hydroxy-oxido-phosphoryl)oxy-oxolan-2-yl]methoxy-[[(2R ,3R,4R,5R)-5-(5-carbamoylpyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-oxido-phosphoryl]oxy-phosphinic acid |
5702630 |
[(2R,3R,4S,5S)-2-(6-aminopurin-9-yl)-5-[[[[(2S,3S,4R,5R)-5-(5-carbamoylpyridin-1-yl)-3,4-dihydroxy-oxola n-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxymethyl]-4-hydroxy-oxolan-3-yl]oxyphosphonic acid |
internal high similarity DBLink | Rows returned: 2 | |
active | Cluster 306 | Additional Members: 11 | Rows returned: 0 | |
|